COGT
Price
$5.72
Change
-$0.07 (-1.21%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
651.22M
40 days until earnings call
VRCA
Price
$0.44
Change
-$0.00 (-0.00%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
40.24M
34 days until earnings call
Ad is loading...

COGT vs VRCA

Header iconCOGT vs VRCA Comparison
Open Charts COGT vs VRCABanner chart's image
Cogent Biosciences
Price$5.72
Change-$0.07 (-1.21%)
Volume$29.22K
Capitalization651.22M
Verrica Pharmaceuticals
Price$0.44
Change-$0.00 (-0.00%)
Volume$10.01K
Capitalization40.24M
COGT vs VRCA Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. VRCA commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and VRCA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (COGT: $5.79 vs. VRCA: $0.44)
Brand notoriety: COGT and VRCA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 133% vs. VRCA: 0%
Market capitalization -- COGT: $651.22M vs. VRCA: $40.24M
COGT [@Biotechnology] is valued at $651.22M. VRCA’s [@Biotechnology] market capitalization is $40.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileVRCA’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • VRCA’s FA Score: 0 green, 5 red.
According to our system of comparison, both COGT and VRCA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while VRCA’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 4 bearish.
  • VRCA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, COGT is a better buy in the short-term than VRCA.

Price Growth

COGT (@Biotechnology) experienced а -16.09% price change this week, while VRCA (@Biotechnology) price change was -7.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

COGT is expected to report earnings on May 13, 2025.

VRCA is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($651M) has a higher market cap than VRCA($40.2M). COGT YTD gains are higher at: -25.769 vs. VRCA (-36.829). VRCA has higher annual earnings (EBITDA): -65.9M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. VRCA (46.3M). COGT has less debt than VRCA: COGT (17.5M) vs VRCA (45.9M). VRCA has higher revenues than COGT: VRCA (7.57M) vs COGT (0).
COGTVRCACOGT / VRCA
Capitalization651M40.2M1,619%
EBITDA-271.59M-65.9M412%
Gain YTD-25.769-36.82970%
P/E RatioN/AN/A-
Revenue07.57M-
Total Cash287M46.3M620%
Total Debt17.5M45.9M38%
FUNDAMENTALS RATINGS
COGT vs VRCA: Fundamental Ratings
COGT
VRCA
OUTLOOK RATING
1..100
5551
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8795
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (81) in the Miscellaneous industry is in the same range as VRCA (96) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to VRCA’s over the last 12 months.

COGT's Profit vs Risk Rating (71) in the Miscellaneous industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to VRCA’s over the last 12 months.

COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to VRCA’s over the last 12 months.

COGT's Price Growth Rating (87) in the Miscellaneous industry is in the same range as VRCA (95) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to VRCA’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as VRCA (100) in the Pharmaceuticals Major industry. This means that COGT’s stock grew similarly to VRCA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTVRCA
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
84%
Bullish Trend 23 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRCA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JESSX15.560.06
+0.39%
Janus Henderson Global Sust Eq S
MNDAX23.140.07
+0.30%
MFS New Discovery A
PRMTX148.82N/A
N/A
T. Rowe Price Comm & Tech Investor
RGERX18.80N/A
N/A
Columbia Select Global Equity Inst2
WFEFX13.68N/A
N/A
Allspring International Equity C

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-3.34%
SPHDF - COGT
63%
Loosely correlated
N/A
ENGN - COGT
47%
Loosely correlated
-3.35%
ARWR - COGT
46%
Loosely correlated
-4.20%
IDYA - COGT
44%
Loosely correlated
-9.83%
CRNX - COGT
43%
Loosely correlated
-8.71%
More